Blood lactate measurements alongside qSOFA or NEWS improves the sensitivities of both tools for predicting 28-day in-hospital mortality
Using blood lactate levels alongside either the quick sequential organ failure assessment (qSOFA) or the National Early Warning Score (NEWS) clinical prediction tools, increases the sensitivities of both for the prediction of 28-day in-hospital mortality among emergency department (ED) patients with a suspected infection and at risk of sepsis.
This was the conclusion of a study by researchers from the Department of Intensive Care, Centre Hospitalier du Mans, Le Mans, France.
The World Health Organization defines sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection adding how in 2017, the condition was responsible for around 11 million deaths worldwide, representing almost 20% of all global deaths. Moreover, early detection of sepsis with timely, appropriate interventions increases the likelihood of patient survival.
Consequently, several tools have been developed to assess patients with an infection who are likely to have sepsis including qSOFA and NEWS. However, a 2018 meta-analysis found that qSOFA was associated with a pooled sensitivity of only 60.8% and a pooled specificity of 72.0% for the prediction of mortality.
The NEWS can also be used for predicting intensive care unit (ICU) admission and mortality when used in an ED although a systemic review found that the NEWS area under the receiver operating characteristic curve for mortality prediction, varied from from little better than chance to a good prediction of mortality.
Given the potential value of both tools and measurement of blood lactate levels, for the present study, the French team wondered if modification of the qSOFA and NEWS to incorporate lactate levels, would improve their respective predictive accuracy for adult ED patients with suspected infection.
The French team undertook a retrospective analysis of adult patients with suspected infection and who had blood cultures obtained within the ED and to whom a non-prophylactic antibiotic was given within the ED.
They created three separate clinical prediction tools: qSOFA and NEWS alone; both tools with blood lactate levels incorporated and finally, both qSOFA and NEWS with blood lactate levels measured in tandem. Cut-off scores for qSOFA used were > 2 and NEWS > 7 and blood lactate levels > 2 mmol/L.
The primary outcome measure was in-hospital 28-day all-cause mortality and the secondary outcome, 3-day all-cause mortality.
Blood lactate levels and clinical scoring outcomes
A total of 1003 patients with a median age of 76 years (57% male) were included in the study and by day 28, 13% of patients had died in hospital.
The sensitivities for 28-day mortality were 50% (qSOFA > 2), 69% (qSOFA with lactate), 77% (qSOFA and lactate in tandem). For NEWS, the corresponding sensitivities were 69% (NEWS alone), 80% (NEWS with lactate) and 87% (NEWS with lactate in tandem). In other words, using either qSOFA or NEWS and blood lactate levels in tandem, provided greater sensitivities than either of the prediction tools alone or with lactate levels incorporated into the tool. Similar results were seen for the secondary outcome of 3-day all-cause mortality.
Nevertheless, despite the improved sensitivities for both prediction tools when used alongside blood lactate levels, the corresponding specificities were 66% (qSOFA and lactate in tandem) and 46% (NEWS and lactate in tandem). This, the authors suggested meant that neither combination was an effective means of ‘ruling out’ mortality.
They concluded that though using either tool in tandem with blood lactate was better than incorporating lactate levels into the tool, neither tool optimally predicted in-hospital 28-day mortality.
Citation
Julienne J et al. Prognostic accuracy of using lactate in addition to the quick Sequential Organ Failure Assessment score and the National Early Warning Score for emergency department patients with suspected infection Emerg Med J 2022
